Overview

Varenicline for Gait and Balance Impairment in Parkinson Disease

Status:
Completed
Trial end date:
2018-11-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if varenicline is effective in improving gait and balance impairment in patients with Parkinson disease.
Phase:
Phase 2
Details
Lead Sponsor:
Rush University Medical Center
Treatments:
Varenicline